Chairs:

• Amaia Lujambio, Assistant Professor, Oncological Sciences, Member of The Tisch Cancer Institute, Member of the Precision Immunology Institute at the Icahn School of Medicine at Mount Sinai, New York, USA
• David Pinato, Clinician Scientist and Consultant Medical Oncologist, Department of Surgery and Cancer at Imperial College, London. 
• Marco Sanduzzi, Investigator, Hospital Clínic de Barcelona · BCLC group, Liver Unit, Hospital Clinic of Barcelona, Spain

Speakers:

• The role of the microbiome in oncology , Jennifer Wargo,Professor, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
• The microbiome in liver cancer: from basic to clinical aspects, Tim Greten, Senior Investigator, National Cancer Institute (NCI), Bethesda, USA
• The microbiome in liver cirrhosis. What is the role of FMT?,Debbie Shawcross, Professor of Hepatology and Chronic Liver Failure, Institute of Liver Studies, King’s College Hospital, UK